Accessibility Menu
GoodRx Stock Quote

GoodRx (NASDAQ: GDRX)

$2.11
(-3.0%)
-0.07
Price as of March 3, 2026, 2:27 p.m. ET

KEY DATA POINTS

Current Price
$2.11
Daily Change
(-3.0%) $0.07
Day's Range
$2.03 - $2.21
Previous Close
$2.17
Open
$2.09
Beta
1.75
Volume
3,546,125
Average Volume
3,009,349
Market Cap
$737M
Market Cap / Employee
$2.17M
52wk Range
$1.77 - $5.81
Revenue
N/A
Gross Margin
0.82%
Dividend Yield
N/A
EPS
$0.08
CAPs Rating
N/A
Industry
Health Care Technology

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

GoodRx Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
GDRX-56.43%-95.01%-45.1%-96%
S&P+15.57%+80.16%+12.49%+113%

GoodRx Company Info

GoodRx Holdings, Inc. engages in the business of a consumer-focused digital healthcare platform. The firm offers consumers free access to transparent and lower prices for brand and generic medications, affordable and convenient medical provider consultations via telehealth, and comprehensive healthcare research and information. The company was founded by Trevor Bezdek and Douglas Joseph Hirsch in September 2015 and is headquartered in Santa Monica, CA.

News & Analysis

Financial Health

General

Q4 2025YOY Change
Revenue$194.79M-1.9%
Gross Profit$154.19M-7.8%
Gross Margin79.16%-5.1%
Market Cap$919.86M-48.1%
Market Cap / Employee$1.32M0.0%
Employees697-5.6%
Net Income$5.43M-19.5%
EBITDA$46.95M2.3%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q4 2025YOY Change
Net Cash$261.82M-41.6%
Accounts Receivable$235.75M61.5%
Inventory00.0%

Liabilities

Q4 2025YOY Change
Long Term Debt$533.05M0.1%
Short Term Debt$9.75M-8.3%

Ratios

Q4 2025YOY Change
Return On Assets2.18%1.1%
Return On Invested Capital-4.81%-2.2%

Cash Flow

Q4 2025YOY Change
Free Cash Flow$31.65M-29.0%
Operating Free Cash Flow$32.89M-26.5%

Valuation

MetricQ1 2025Q2 2025Q3 2025Q4 2025YoY Change
Price to Earnings59.3553.6649.2432.19-70.51%
Price to Book2.332.752.321.54-39.47%
Price to Sales2.102.221.841.16-48.52%
Price to Tangible Book Value12.3253.3385.47-35.70-325.22%
Price to Free Cash Flow TTM11.189.398.305.62-42.47%
Enterprise Value to EBITDA38.3343.1136.4225.65-37.35%
Free Cash Flow Yield8.9%10.7%12.1%17.8%73.83%
Return on Equity4.4%5.3%4.9%4.5%105.90%
Total Debt$541.19M$547.54M$545.14M$542.81M-0.11%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.